70 related articles for article (PubMed ID: 2659238)
1. The LFA-1 antigen in human B lymphocyte activation.
Zola H; Furness V; Nikoloutsopoulos A; Neoh SH; Barclay S; Starr R; Day A; Russ GR
Dis Markers; 1989; 7(2):95-104. PubMed ID: 2659238
[TBL] [Abstract][Full Text] [Related]
2. Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow).
Shields JG; Smith SH; Strobel S; Levinsky RJ; Defrance T; De Vries J; Banchereau J; Callard RE
Eur J Immunol; 1988 Feb; 18(2):255-9. PubMed ID: 2832180
[TBL] [Abstract][Full Text] [Related]
3. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
Smith SH; Rigley KP; Callard RE
Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315
[TBL] [Abstract][Full Text] [Related]
4. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans.
Fischer A; Durandy A; Sterkers G; Griscelli C
J Immunol; 1986 May; 136(9):3198-203. PubMed ID: 3514755
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis.
Björck P; Paulie S
Immunology; 1993 Feb; 78(2):218-25. PubMed ID: 7682536
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1).
Mishra GC; Berton MT; Oliver KG; Krammer PH; Uhr JW; Vitetta ES
J Immunol; 1986 Sep; 137(5):1590-8. PubMed ID: 3091687
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-4 receptor on human T and B lymphocytes.
Zola H; Flego L; Weedon H
Cell Immunol; 1993 Aug; 150(1):149-58. PubMed ID: 7688267
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
9. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.
Clark EA; Shu G
J Immunol; 1987 Feb; 138(3):720-5. PubMed ID: 3492530
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of LFA-1 and ICAM-1 on human primary B-lymphocytes.
Brändén H; Lundgren E
Cell Immunol; 1993 Mar; 147(1):64-72. PubMed ID: 8096439
[TBL] [Abstract][Full Text] [Related]
11. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
Kindler V; Zubler RH
J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
[TBL] [Abstract][Full Text] [Related]
12. A B cell-restricted activation antigen (B8.7) functionally related to the low molecular weight B cell growth factor receptor.
Leprince C; Richard Y; Krief P; Treton D; Boucheix C; Galanaud P
J Immunol; 1988 Jan; 140(1):100-7. PubMed ID: 3257225
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of an early activation marker restricted to human B cells.
Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
[TBL] [Abstract][Full Text] [Related]
14. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.
Valentine MA; Clark EA; Shu GL; Norris NA; Ledbetter JA
J Immunol; 1988 Jun; 140(12):4071-8. PubMed ID: 3259604
[TBL] [Abstract][Full Text] [Related]
15. Changes in CD44 expression during B cell differentiation in the human tonsil.
Kremmidiotis G; Zola H
Cell Immunol; 1995 Apr; 161(2):147-57. PubMed ID: 7535194
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
Moore K; Nesbitt AM
Immunology; 1987 Jun; 61(2):159-65. PubMed ID: 2954898
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human tumour necrosis factor beta (TNF beta) on activation, proliferation and differentiation of human B lymphocytes.
Zola H; Nikoloutsopoulos A
Immunology; 1989 Jun; 67(2):231-6. PubMed ID: 2787779
[TBL] [Abstract][Full Text] [Related]
18. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
